Chronic Illnesses: Medical Treatments

Department of Health and Social Care written question – answered on 26th July 2022.

Alert me about debates like this

Photo of Feryal Clark Feryal Clark Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 June 2022 to Question 23448 on Chronic Illnesses: Medical Treatments, whether his Department has undertaken a comparative assessment of international access to innovative medicines for people with long-term health conditions.

Photo of James Morris James Morris Assistant Whip, The Parliamentary Under-Secretary for Health and Social Care

No specific assessment has been made. However, the Office for Life Sciences produces the annual ‘Life Science Competitiveness Indicators’ which includes international comparisons on the percentage of new medicines available, time to availability for new medicines and uptake of new medicines recommended by the National Institute for Health and Care Excellence, which measures relative adoption of new medicines in the United Kingdom in comparison to other countries.

In 2021, NHS England published the International Comparison Medicines Uptake report on treatments for cystic fibrosis, severe asthma, varenicline-assisted smoking cessation and hepatitis C, which aims to establish a methodology in order to make international comparisons of medicines uptake.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.